➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Colorcon
Dow
Boehringer Ingelheim
Johnson and Johnson
McKinsey
Medtronic

Last Updated: August 14, 2020

DrugPatentWatch Database Preview

METHOTREXATE PRESERVATIVE FREE Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

When do Methotrexate Preservative Free patents expire, and when can generic versions of Methotrexate Preservative Free launch?

Methotrexate Preservative Free is a drug marketed by Fresenius Kabi Usa and Hospira and is included in three NDAs.

The generic ingredient in METHOTREXATE PRESERVATIVE FREE is methotrexate sodium. There are twenty drug master file entries for this compound. Twenty-three suppliers are listed for this compound. Additional details are available on the methotrexate sodium profile page.

US ANDA Litigation and Generic Entry Outlook for Methotrexate Preservative Free

A generic version of METHOTREXATE PRESERVATIVE FREE was approved as methotrexate sodium by WEST-WARD PHARMS INT on September 16th, 1986.

  Start Trial

Drug patent expirations by year for METHOTREXATE PRESERVATIVE FREE
Recent Clinical Trials for METHOTREXATE PRESERVATIVE FREE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
EMD SeronoPhase 0
PfizerPhase 0
Aaron BosterPhase 0

See all METHOTREXATE PRESERVATIVE FREE clinical trials

Pharmacology for METHOTREXATE PRESERVATIVE FREE

US Patents and Regulatory Information for METHOTREXATE PRESERVATIVE FREE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Fresenius Kabi Usa METHOTREXATE PRESERVATIVE FREE methotrexate sodium INJECTABLE;INJECTION 040266-001 Feb 26, 1999 AP RX No No   Start Trial   Start Trial   Start Trial
Hospira METHOTREXATE PRESERVATIVE FREE methotrexate sodium INJECTABLE;INJECTION 011719-014 Apr 13, 2005 DISCN No No   Start Trial   Start Trial   Start Trial
Fresenius Kabi Usa METHOTREXATE PRESERVATIVE FREE methotrexate sodium INJECTABLE;INJECTION 040265-001 Feb 26, 1999 AP RX No No   Start Trial   Start Trial   Start Trial
Hospira METHOTREXATE PRESERVATIVE FREE methotrexate sodium INJECTABLE;INJECTION 011719-011 Apr 13, 2005 DISCN No No   Start Trial   Start Trial   Start Trial
Hospira METHOTREXATE PRESERVATIVE FREE methotrexate sodium INJECTABLE;INJECTION 011719-013 Apr 13, 2005 DISCN Yes No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Colorcon
Dow
Moodys
Boehringer Ingelheim
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.